![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, September 11, 2014 8:06:41 PM
According to iHub on 08/15/14 there were 5,336,000 TNIB shares short.
There are about 90,500,000 shares outstanding according to the company.
All shareholders will have to withdraw all of their shares from their Brokerage Account in connection with the mandatory surrender of TNIB share certificates in order to
receive the Cytocom, Inc. dividend. See the Sept. 9th Press Release: http://ih.advfn.com/p.php?pid=nmona&article=63523225
As it appears that most shareholders will want the dividend there is not going to be much of a float left in Brokerage accounts from which to borrow stock to short. Short positions could be called to cover if the stock is no longer available. Of course shorts are not dumb, so it is possible that most have already covered in the last 3 weeks.
From the Press Release:
"CYTOCOM INC. SPIN OUT
We have received numerous calls concerning the Cytocom Inc. dividend and below is additional information for shareholders.
Our shareholders will receive one common share of Cytocom Inc. for every one share of Company common stock held by such shareholders as of 5:00 p.m., Eastern Time, on September 30, 2014, which is the "record date" for the distribution.
However, to the extent that a shareholder of the Company sells a portion or all of that stockholder's shares of our common stock prior to the record date, such stockholder also will be pro-rata selling the right to receive common shares of Cytocom Inc. through the distribution.
To receive the Cytocom Inc. share dividend, all shareholders must surrender all existing share certificates to the Company's transfer agent. Shares in Street Name will need to be in the name of the shareholder when presented to the transfer agent for the dividend.
There is no electronic transfer so shareholders must obtain Company certificates in their name from their broker and present them to our transfer agent, Guardian Register & Transfer Inc.: 7951 South West 6th Street, Suite 216 Plantation, FL 33324, Tel: (954) 915-0105, Email: clientservices@guardiantransfer.net,
The below link will provide a sample letter to brokers that can be sent to your broker to convert your shares back into certificate form : http://www.tnibiotech.com/investor-relations/letter-of-instruction-to-broker
When shareholders present their Company share certificates to our transfer agent, our transfer agent will then send to each such shareholder proof of Cytocom Inc. common stock ownership, as of the record date. Cytocom Inc. shares will be kept in book entry until a Registration Statement on Form S-1 is declared effective by the Securities and Exchange Commission unless a shareholder requests differently. Once the transfer agent books the ownership of Cytocom Inc. common stock, as of September 30, 2014, the Company share certificates will be returned to the shareholder.
If you have any questions please do not hesitate to get in touch with either our transfer agent at elson@guardiantransfer.net or Kirsten Bartholomew at Kirsten.Bartholomew@tnibiotech.com."
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM